<SEC-DOCUMENT>0001193125-25-044830.txt : 20250304
<SEC-HEADER>0001193125-25-044830.hdr.sgml : 20250304
<ACCEPTANCE-DATETIME>20250304070524
ACCESSION NUMBER:		0001193125-25-044830
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20250304
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250304
DATE AS OF CHANGE:		20250304

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CalciMedica, Inc.
		CENTRAL INDEX KEY:			0001534133
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				452120079
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39538
		FILM NUMBER:		25701501

	BUSINESS ADDRESS:	
		STREET 1:		505 COAST BOULEVARD SOUTH
		STREET 2:		SUITE 307
		CITY:			LA JOLLA
		STATE:			CA
		ZIP:			92037
		BUSINESS PHONE:		858-952-5500

	MAIL ADDRESS:	
		STREET 1:		505 COAST BOULEVARD SOUTH
		STREET 2:		SUITE 307
		CITY:			LA JOLLA
		STATE:			CA
		ZIP:			92037

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CalciMedica, Inc. /DE/
		DATE OF NAME CHANGE:	20230322

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	GRAYBUG VISION, INC.
		DATE OF NAME CHANGE:	20170717

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	GRAYBUG, Inc.
		DATE OF NAME CHANGE:	20150303
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d824505d8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-types="http://fasb.org/us-types/2024" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:calc="http://imetrix.edgar-online.com/20250304" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>8-K</title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
   <body><div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric id="Hidden_dei_SecurityExchangeName" name="dei:SecurityExchangeName" contextRef="duration_2025-03-04_to_2025-03-04">NASDAQ</ix:nonNumeric> <ix:nonNumeric name="dei:AmendmentFlag" contextRef="duration_2025-03-04_to_2025-03-04" id="ixv-323">false</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey" name="dei:EntityCentralIndexKey" contextRef="duration_2025-03-04_to_2025-03-04">0001534133</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xlink:type="simple" xlink:href="calc-20250304.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase"/> </ix:references> <ix:resources> <xbrli:context id="duration_2025-03-04_to_2025-03-04"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-03-04</xbrli:startDate> <xbrli:endDate>2025-03-04</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">UNITED STATES</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">SECURITIES AND EXCHANGE COMMISSION</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">WASHINGTON, D.C. 20549</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">FORM <span style="white-space:nowrap"><ix:nonNumeric name="dei:DocumentType" contextRef="duration_2025-03-04_to_2025-03-04" id="ixv-334">8-K</ix:nonNumeric></span></p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">CURRENT REPORT</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Pursuant to Section&#160;13 or 15(d)</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">of the Securities Exchange Act of 1934</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2025-03-04_to_2025-03-04" format="ixt:datemonthdayyearen" id="ixv-335">March&#160;4, 2025</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Date of Report (Date of earliest event reported)</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityRegistrantName" contextRef="duration_2025-03-04_to_2025-03-04" id="ixv-336">CalciMedica, Inc.</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Exact name of registrant as specified in its charter)</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"/>
<td style="vertical-align:bottom"/>
<td style="width:32%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:32%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="duration_2025-03-04_to_2025-03-04" format="ixt-sec:stateprovnameen" id="ixv-337">Delaware</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityFileNumber" contextRef="duration_2025-03-04_to_2025-03-04" id="ixv-338">001-39538</ix:nonNumeric></span></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="duration_2025-03-04_to_2025-03-04" id="ixv-339">45-2120079</ix:nonNumeric></span></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top;text-align:center"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(State or other jurisdiction</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">of incorporation)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Commission</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">File Number)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(IRS Employer</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Identification No.)</p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:50%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:48%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom;text-align:center"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="duration_2025-03-04_to_2025-03-04" id="ixv-340">505 Coast Boulevard South</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressAddressLine2" contextRef="duration_2025-03-04_to_2025-03-04" id="ixv-341">Suite 307</ix:nonNumeric><br/><ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="duration_2025-03-04_to_2025-03-04" id="ixv-342">La Jolla</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="duration_2025-03-04_to_2025-03-04" format="ixt-sec:stateprovnameen" id="ixv-343">California</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;text-align:center"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="duration_2025-03-04_to_2025-03-04" id="ixv-344">92037</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold">(Address of principal executive offices)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold">(Zip Code)</span></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Registrant&#8217;s telephone number, including area code: <ix:nonNumeric name="dei:CityAreaCode" contextRef="duration_2025-03-04_to_2025-03-04" id="ixv-345">(858)</ix:nonNumeric> <span style="white-space:nowrap"><ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="duration_2025-03-04_to_2025-03-04" id="ixv-346">952-5500</ix:nonNumeric></span></p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Not Applicable</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Former name or former address, if changed since last report)</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form <span style="white-space:nowrap">8-K</span> filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions:</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left"><ix:nonNumeric name="dei:WrittenCommunications" contextRef="duration_2025-03-04_to_2025-03-04" format="ixt-sec:boolballotbox" id="ixv-347">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left"><ix:nonNumeric name="dei:SolicitingMaterial" contextRef="duration_2025-03-04_to_2025-03-04" format="ixt-sec:boolballotbox" id="ixv-348">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Soliciting material pursuant to Rule <span style="white-space:nowrap">14a-12</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14a-12)</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="duration_2025-03-04_to_2025-03-04" format="ixt-sec:boolballotbox" id="ixv-349">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">14d-2(b)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14d-2(b))</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" contextRef="duration_2025-03-04_to_2025-03-04" format="ixt-sec:boolballotbox" id="ixv-350">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">13e-4(c)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.13e-4(c))</span></p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Securities registered pursuant to Section&#160;12(b) of the Act:</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"/>
<td style="vertical-align:bottom"/>
<td style="width:32%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:32%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Title of each class</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Trading<br/>Symbol(s)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Name of each exchange<br/>on which registered</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;text-align:center"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2025-03-04_to_2025-03-04" id="ixv-351">Common Stock, $0.0001, par value per share</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2025-03-04_to_2025-03-04" id="ixv-352">CALC</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"> <span style=" -sec-ix-hidden:Hidden_dei_SecurityExchangeName">The Nasdaq Capital Market</span> </td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;&#8201;230.405 of this chapter) or Rule <span style="white-space:nowrap">12b-2</span> of the Securities Exchange Act of 1934 <span style="white-space:nowrap">(&#167;&#8201;240.12b-2</span> of this chapter).</p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Emerging growth company <ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="duration_2025-03-04_to_2025-03-04" format="ixt-sec:boolballotbox" id="ixv-353">&#9746;</ix:nonNumeric></p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act. <ix:nonNumeric name="dei:EntityExTransitionPeriod" contextRef="duration_2025-03-04_to_2025-03-04" format="ixt-sec:boolballotbox" id="ixv-354">&#9744;</ix:nonNumeric></p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p></div></div>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Item&#8201;7.01 Regulation FD Disclosure. </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On March&#160;4, 2025, CalciMedica, Inc. (the &#8220;Company&#8221;) issued a press release announcing data based on a <span style="white-space:nowrap">post-hoc</span> analysis from the previously completed Phase 2 CARDEA trial of Auxora patients with severe <span style="white-space:nowrap">COVID-19</span> pneumonia. A copy of the press release is attached hereto as Exhibit 99.1. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The information in this Item 7.01 of this Current Report on Form <span style="white-space:nowrap">8-K,</span> including the attached Exhibit 99.1, is being furnished and shall not be deemed &#8220;filed&#8221; for the purposes of Section&#160;18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section or Sections 11 and 12(a)(2) of the Securities Act of 1933, as amended. The information contained in this Item 7.01, including Exhibit 99.1, shall not be incorporated by reference into any filing we make with the U.S. Securities and Exchange Commission (&#8220;SEC&#8221;), whether before or after the date hereof, regardless of any general incorporation language in such filing. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Item&#8201;8.01 Other Events. </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On March&#160;4, 2025, the Company announced new data from a <span style="white-space:nowrap">post-hoc</span> analysis of the previously completed CARDEA trial, the Company&#8217;s Phase 2 trial evaluating Auxora for the treatment of severe <span style="white-space:nowrap">COVID-19</span> pneumonia. The study included a subset of 38 patients who enrolled with Acute Kidney Injury (&#8220;AKI&#8221;), defined as an estimated glomerular filtration rate (&#8220;eGFR&#8221;) &#8804; 60 ml/min/1.73 m&#178;, in addition to moderate or severe respiratory failure, which was an inclusion criterion. Within this subset, patients treated with Auxora showed a 62.7% relative reduction versus placebo in mortality at day 30 which persisted through day 60. Seven out of 15 (46.7%) of patients on placebo died by day 30 and day 60 as compared to 4 out of 23 (17.4%) of patients on Auxora. Auxora exhibited an absolute reduction in mortality of 29.3% in this subset. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This reduction in mortality in the patient subset with AKI exceeded that of the entire study population. In the entire study population (n = 261), a 56.3% (p = 0.017) relative reduction versus placebo in mortality at day 30 was observed, with an absolute reduction of 9.9% versus placebo. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company summarized previously disclosed data supporting the role of CRAC channel inhibition as a potential therapeutic mechanism in AKI, including: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:4%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">In preclinical biomarker studies, rats with AKI following ischemic reperfusion injury had decreased Th17 cells in their kidneys when receiving a CRAC inhibitor versus control, highlighting immunomodulatory effects. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:4%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">In <span style="white-space:nowrap">in-vitro</span> experiments, CRAC channel inhibition ameliorated injury to podocyte cells (kidney cells involved in filtration) caused by high glucose or angiotensin II, highlighting tissue-protective effects. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:4%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">In preclinical outcome studies, glomerular filtration rates recovered more quickly and mortality was reduced in rats with severe or moderately severe AKI that received Auxora versus placebo. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:4%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">In clinical trial biomarker studies, CARDEA patients who received Auxora versus placebo had changes in cardiorenal biomarkers&#8212;increases in <span style="white-space:nowrap">angiopoietin-1</span> and decreases in <span style="white-space:nowrap">angiopoietin-2</span> and <span style="white-space:nowrap">D-dimers&#8212;which</span> have been linked to the prevention of endothelial damage in prior studies and were correlated with improved outcomes in CARDEA. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:4%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">At doses used experimentally and clinically, Auxora potentially provides a therapeutic window to treat acute critical illnesses without increasing risk of infection. </p></td></tr></table> <p style="font-size:18pt; margin-top:0pt; margin-bottom:0pt">&#160;</p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">1 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Cautionary Statement Regarding Forward Looking Statements </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Current Report on <span style="white-space:nowrap">Form&#160;8-K&#160;contains</span> forward-looking statements which include, but are not limited to, statements related to the Company&#8217;s business strategy; results of <span style="white-space:nowrap">post-hoc</span> analyses from the previously completed Phase 2 CARDEA trial of Auxora and the Company&#8217;s ongoing and planned clinical trials and the timing and design, thereof, and the expected timing for the release of data from those trials; the potential benefits of Auxora for the treatment of AKI; and the potential of the Company&#8217;s proprietary technology to provide therapeutic benefits in life-threatening inflammatory and immunologic diseases. These forward-looking statements are subject to the safe harbor provisions under the Private Securities Litigation Reform Act of 1995. The Company&#8217;s expectations and beliefs regarding these matters may not materialize. Actual outcomes and results may differ materially from those contemplated by these forward-looking statements as a result of uncertainties, risks, and changes in circumstances, including, but not limited to, risks and uncertainties related to: the impact of fluctuations in global financial markets on the Company&#8217;s business and the actions it may take in response thereto; the Company&#8217;s ability to execute its plans and strategies; the ability to obtain and maintain regulatory approval for Auxora; results from clinical trials or preclinical studies, including preliminary results, may not be indicative of results that may be observed in the future; potential safety and other complications from Auxora; the scope progress and expansion of developing and commercializing Auxora; the size and growth of the market therefor and the rate and degree of market acceptance thereof; economic, business, competitive, and/or regulatory factors affecting the business of the Company generally; the impact of government laws and regulations; and the Company&#8217;s need for additional capital. Additional risks and uncertainties that could cause actual outcomes and results to differ materially from those contemplated by the forward-looking statements are under the caption &#8220;Risk Factors&#8221; and elsewhere in the Company&#8217;s most recent filings with the SEC, including its Quarterly Report on <span style="white-space:nowrap">Form&#160;10-Q&#160;for</span> the quarter ended September&#160;30, 2024 and any subsequent reports on <span style="white-space:nowrap"><span style="white-space:nowrap">Form&#160;10-K,&#160;Form&#160;10-Q&#160;or</span></span> <span style="white-space:nowrap">Form&#160;8-K&#160;filed</span> with the SEC from time to time. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The forward-looking statements included in this Current Report on <span style="white-space:nowrap">Form&#160;8-K&#160;are</span> made only as of the date hereof. The Company assumes no obligation and does not intend to update these forward-looking statements, except as required by law. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Item&#8201;9.01 Financial Statements and Exhibits. (d)&#160;Exhibits. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td/>

<td style="vertical-align:bottom;width:7%"/>
<td style="width:90%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap;text-align:center"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;text-align:center">Exhibit&#160;No.</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman">Description</p></td></tr>


<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">99.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d824505dex991.htm">Press release dated March&#160;4, 2025. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">104</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Cover Page Interactive Data File (embedded within the Inline XBRL document).</td></tr>
</table> <p style="font-size:18pt; margin-top:0pt; margin-bottom:0pt">&#160;</p>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">SIGNATURES </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0">


<tr>

<td style="width:44%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:4%"/>

<td style="vertical-align:bottom"/>
<td style="width:5%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:44%"/></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" colspan="3">CalciMedica, Inc.</td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"/>
<td style="height:12pt" colspan="2"/>
<td style="height:12pt" colspan="2"/>
<td style="height:12pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom">Date: March&#160;4, 2025</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">By:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman;text-align:center"><span style="font-style:italic">/s/ A. Rachel Leheny, Ph.D.</span></p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">Name:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;text-align:center">A. Rachel Leheny, Ph.D.</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">Title:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;text-align:center">Chief Executive Officer</td></tr>
</table>
</div></div>

</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>d824505dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt; margin-left:8%" ALIGN="center">


<IMG SRC="g824505g0304094350239.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CalciMedica Presents AKI Data from a <FONT STYLE="white-space:nowrap">Post-Hoc</FONT> Analysis of the
Phase 2 CARDEA trial of Auxora<SUP STYLE="font-size:75%; vertical-align:top">&#153;</SUP> in Severe <FONT STYLE="white-space:nowrap">COVID-19</FONT> Pneumonia at the 30<SUP STYLE="font-size:75%; vertical-align:top">th</SUP> International
AKI&nbsp;&amp; CRRT Conference </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>62.7% relative reduction in mortality at day 30, which persisted through day 60, for patients treated
with Auxora versus placebo in subset of patients in CARDEA with AKI </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">LA JOLLA, Calif., Mar. 4, 2025<B> </B>&#150; CalciMedica Inc.
(&#147;CalciMedica&#148; or the &#147;Company&#148;) (Nasdaq: CALC), a clinical-stage biopharmaceutical company focused on developing novel calcium release-activated calcium (CRAC) channel inhibition therapies for acute and chronic inflammatory and
immunologic illnesses, today announced&nbsp;that Sudarshan Hebbar, M.D., Chief Medical Officer of CalciMedica, delivered a plenary presentation at the 30<SUP STYLE="font-size:75%; vertical-align:top">th</SUP> International Acute Kidney Injury and
Continuous Renal Replacement Therapy Conference (AKI&nbsp;&amp; CRRT) on March&nbsp;3, 2025 in San Diego, CA. The presentation outlined the role of CRAC channels in acute kidney injury (AKI) pathophysiology and included new data highlighting the
potential of CalciMedica&#146;s lead product candidate, Auxora<SUP STYLE="font-size:75%; vertical-align:top">&#153;</SUP>, in AKI. CalciMedica is currently conducting a Phase 2 trial of Auxora in patients with Stage 2 or Stage 3 AKI and acute
hypoxemic respiratory failure, which is expected to read out in 2025. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The new data presented were based on a
<FONT STYLE="white-space:nowrap">post-hoc</FONT> analysis from the previously completed Phase 2 CARDEA trial of Auxora in severe <FONT STYLE="white-space:nowrap">COVID-19</FONT> pneumonia. The study included 38 patients who enrolled with AKI,
defined as an estimated glomerular filtration rate (eGFR) &#8804; 60 ml/min/1.73 m&sup2;, in addition to moderate or severe respiratory failure, which was an inclusion criterion. Within this subset: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Patients treated with Auxora showed a 62.7% relative reduction versus placebo in mortality at day 30 which
persisted through day 60. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">7 out of 15 (46.7%) patients on placebo died by day 30 and day 60 as compared to 4 out of 23 (17.4%) patients on
Auxora. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Auxora exhibited an absolute reduction in mortality of 29.3%. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This reduction in mortality in the patient subset with AKI exceeded that of the entire study population. In the entire population (n = 261), a 56.3% (p =
0.017) relative reduction versus placebo in mortality at day 30 was observed, with an absolute reduction of 9.9% versus placebo. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In his presentation,
Dr.&nbsp;Hebbar also summarized previously disclosed data supporting the role of CRAC channel inhibition as a potential therapeutic mechanism in AKI. Key data include: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">In preclinical biomarker studies, rats with AKI following ischemic reperfusion injury had decreased Th17 cells in
their kidneys when receiving a CRAC inhibitor versus control, highlighting immunomodulatory effects. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">In <FONT STYLE="white-space:nowrap">in-vitro</FONT> experiments, CRAC channel inhibition ameliorated injury to
podocyte cells (kidney cells involved in filtration) caused by high glucose or angiotensin II, highlighting tissue-protective effects. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">In preclinical outcome studies, GFRs recovered more quickly and mortality was reduced in rats with severe or
moderately severe AKI that received Auxora versus placebo. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">In clinical trial biomarker studies, CARDEA patients who received Auxora versus placebo had changes in
cardiorenal biomarkers&#151;increases in <FONT STYLE="white-space:nowrap">angiopoietin-1</FONT> and decreases in <FONT STYLE="white-space:nowrap">angiopoietin-2</FONT> and <FONT STYLE="white-space:nowrap">D-dimers&#151;which</FONT> have been linked
to the prevention of endothelial damage in prior studies and were correlated with improved outcomes in CARDEA. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">At doses used experimentally and clinically, Auxora potentially provides a therapeutic window to treat acute
critical illnesses without increasing risk of infection. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;As illustrated by these data, the biological rationale for CRAC channel
inhibition as a potential therapeutic mechanism for AKI is compelling,&#148; said Sudarshan Hebbar, M.D., Chief Medical Officer of CalciMedica. &#147;The <FONT STYLE="white-space:nowrap">post-hoc</FONT> analysis from CARDEA is especially relevant
given that the 62.7% relative reduction in mortality was observed in patients with both kidney failure and respiratory failure, which mirrors the intended patient population for our ongoing Phase 2 KOURAGE study.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The presentation is now available on the Medical Events&nbsp;&amp; Presentations section of CalciMedica&#146;s IR website at<BR>
<U>https://ir.calcimedica.com/news-events/medical-events-publications.</U> </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About CalciMedica </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CalciMedica&nbsp;is a clinical-stage biopharmaceutical company focused on developing novel CRAC channel inhibition therapies for inflammatory and immunologic
diseases.&nbsp;CalciMedica&#146;s&nbsp;proprietary technology targets the inhibition of CRAC channels to modulate the immune response and protect against tissue cell injury, with the potential to provide therapeutic benefits in life-threatening
inflammatory and immunologic diseases for which there are currently no approved therapies.&nbsp;CalciMedica&#146;s&nbsp;lead product candidate&nbsp;Auxora<SUP STYLE="font-size:75%; vertical-align:top">&#153;</SUP> has demonstrated positive and
consistent clinical results in multiple completed efficacy clinical trials. CalciMedica&nbsp;has announced data for a Phase 2b trial (called CARPO &#150;&nbsp;<U>NCT04681066</U>) in patients with acute pancreatitis (AP) and accompanying systemic
inflammatory response syndrome (SIRS). The Company has also completed a Phase 2 trial (called CARDEA &#150;&nbsp;<U>NCT04345614</U>) in patients with COVID pneumonia. The Company is currently conducting a Phase 2 trial (called KOURAGE
&#150;<U>NCT06374797</U>) in patients with acute kidney injury (AKI) with associated acute hypoxemic respiratory failure (AHRF) with data expected in 2025 and continuing to support the ongoing Phase 1/2 trial (called CRSPA
&#150;&nbsp;<U>NCT04195347</U>) in pediatric patients with asparaginase-induced pancreatic toxicity (AIPT) with data expected in 2025.&nbsp;CalciMedica&nbsp;was founded by scientists from Torrey Pines Therapeutics and the&nbsp;Harvard CBR Institute
for Biomedical Research, and is headquartered in&nbsp;La Jolla, CA.&nbsp;For more information, please visit&nbsp;<U>www.calcimedica.com</U>. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Forward-Looking Statements </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This communication contains
forward-looking statements which include, but are not limited to, results of <FONT STYLE="white-space:nowrap">post-hoc</FONT> analyses from the previously completed Phase 2 CARDEA trial of Auxora and&nbsp;CalciMedica&#146;s&nbsp;ongoing and planned
clinical trials and the timing and design thereof, and the expected timing for the release of data from those trials, including its ongoing Phase 1/2 CRSPA trial of Auxora in pediatric patients with AIPT and its ongoing Phase 2 KOURAGE trial of
Auxora in AKI with associated AHRF; the potential benefits of Auxora for the treatment of AP, AKI and AIPT; and the potential of&nbsp;CalciMedica&#146;s&nbsp;proprietary technology to provide therapeutic benefits in life-threatening inflammatory and
immunologic diseases. These forward-looking statements are subject to the safe harbor provisions under the Private Securities Litigation Reform Act of 1995.&nbsp;CalciMedica&#146;s&nbsp;expectations and beliefs
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
regarding these matters may not materialize. Actual outcomes and results may differ materially from those contemplated by these forward-looking statements as a result of uncertainties, risks, and
changes in circumstances. Risks and uncertainties that could cause actual outcomes and results to differ materially from those contemplated by the forward-looking statements are included under the caption &#147;Risk Factors&#148;
in&nbsp;CalciMedica&#146;s&nbsp;Quarterly Report on Form <FONT STYLE="white-space:nowrap">10-Q</FONT> for the quarter ended&nbsp;September 30, 2024, filed with the&nbsp;U.S. Securities and Exchange Commission&nbsp;(SEC) on&nbsp;November 13, 2024,
and elsewhere in&nbsp;CalciMedica&#146;s&nbsp;subsequent reports on Form <FONT STYLE="white-space:nowrap">10-K,</FONT> Form <FONT STYLE="white-space:nowrap">10-Q</FONT> or Form <FONT STYLE="white-space:nowrap">8-K</FONT> filed with
the&nbsp;SEC&nbsp;from time to time and available at&nbsp;<U>www.sec.gov</U>. These documents can be accessed on&nbsp;CalciMedica&#146;s&nbsp;web page
at&nbsp;<U><FONT STYLE="white-space:nowrap">ir.calcimedica.com/financials-filings/sec-filings</FONT></U>. The forward-looking statements contained herein are made as of the date hereof, and&nbsp;CalciMedica&nbsp;undertakes no obligation to update
them after this date, except as required by law. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Contact Information </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Argot Partners </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Sarah Sutton/Kevin Murphy </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>calcimedica@argotpartners.com </U></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(212) <FONT
STYLE="white-space:nowrap">600-1902</FONT> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>calc-20250304.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20241122.1 -->
<!-- Creation date: 3/4/2025 1:33:04 PM Eastern Time -->
<!-- Copyright (c) 2025 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric"
  xmlns:num="http://www.xbrl.org/dtr/type/numeric"
  xmlns:us-types="http://fasb.org/us-types/2024"
  xmlns:calc="http://imetrix.edgar-online.com/20250304"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://imetrix.edgar-online.com/20250304"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd" namespace="http://xbrl.sec.gov/dei/2024" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2024/naics-2024.xsd" namespace="http://xbrl.sec.gov/naics/2024" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="calc-20250304_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="calc-20250304_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://imetrix.edgar-online.com//20250304/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>calc-20250304_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20241122.1 -->
<!-- Creation date: 3/4/2025 1:33:04 PM Eastern Time -->
<!-- Copyright (c) 2025 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line Two</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line Two</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security 12b Title</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:type="locator" xlink:label="dei_EntityExTransitionPeriod" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityExTransitionPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Ex Transition Period</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityExTransitionPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Ex Transition Period</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>calc-20250304_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20241122.1 -->
<!-- Creation date: 3/4/2025 1:33:04 PM Eastern Time -->
<!-- Copyright (c) 2025 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://imetrix.edgar-online.com//20250304/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="calc-20250304.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com//20250304/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="22.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="23.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="24.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="26.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="27.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="28.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="29.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="30.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="31.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="32.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine2" order="33.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="34.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="35.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="42.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="43.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="44.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="45.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:type="locator" xlink:label="dei_EntityExTransitionPeriod" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityExTransitionPeriod" order="46.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>g824505g0304094350239.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g824505g0304094350239.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  \ 2X# 2(  A$! Q$!_\0
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2B@!:*2B@!:*2B@!:*2B@#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45470140705232">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Mar. 04, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001534133<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar.  04,  2025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">CalciMedica, Inc.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-39538<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">45-2120079<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">505 Coast Boulevard South<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 307<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">La Jolla<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">92037<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(858)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">952-5500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Common Stock, $0.0001, par value per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CALC<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( *LX9%H'04UB@0   +$    0    9&]C4')O<',O87!P+GAM
M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG
M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGD<Z,STA)8*O4'J@)I9GF
M3?X.CD:?<@X>K7A.YNJQ<&4GPZ4A!0W_<FW>J=0U[R;UEA_6\#MI7E!+ P04
M    " "K.&1:&,)\N>X    K @  $0   &1O8U!R;W!S+V-O<F4N>&ULS9+!
M3L,P#(9?!>7>.DT9AZCK96BG(2$Q"<0M2KPMHDFCQ*C=V].&K1."!^ 8^\_G
MSY(;':3N(S['/F DB^EN=)U/4H<U.Q$%"9#T"9U*Y93P4_/01Z=H>L8C!*4_
MU!%!</X #DD910IF8!$6(FL;HZ6.J*B/%[S1"SY\QB[#C ;LT*&G!%59 6OG
MB>$\=@W< #.,,+KT74"S$'/U3VSN +LDQV27U# ,Y5#GW+1#!6]/NY>\;F%]
M(N4U3K^2E70.N&;7R:_UYG&_9:W@8E7PNN#W^TI(OI)"O,^N/_QNPJXW]F#_
ML?%5L&W@UUVT7U!+ P04    " "K.&1:F5R<(Q &  "<)P  $P   'AL+W1H
M96UE+W1H96UE,2YX;6SM6EMSVC@4?N^OT'AG]FT+QC:!MK03<VEVV[29A.U.
M'X416(UL>621A'^_1S80RY8-[9)-NIL\!"SI^\Y%1^?H.'GS[BYBZ(:(E/)X
M8-DOV]:[MR_>X%<R)!%!,!FGK_# "J5,7K5::0##.'W)$Q+#W(*+"$MX%,O6
M7.!;&B\CUNJTV]U6A&ELH1A'9&!]7BQH0-!445IO7R"TY1\S^!7+5(UEHP$3
M5T$FN8BT\OELQ?S:WCYES^DZ'3*!;C ;6"!_SF^GY$Y:B.%4PL3 :F<_5FO'
MT=)(@(+)?90%NDGVH],5"#(-.SJ=6,YV?/;$[9^,RMIT-&T:X./Q>#BVR]*+
M<!P$X%&[GL*=]&R_I$$)M*-IT&38]MJND::JC5-/T_=]W^N;:)P*C5M/TVMW
MW=..B<:MT'@-OO%/A\.NB<:KT'3K:28G_:YKI.D6:$)&X^MZ$A6UY4#3( !8
M<';6S-(#EEXI^G64&MD=N]U!7/!8[CF)$?[&Q036:=(9EC1&<IV0!0X -\31
M3%!\KT&VBN#"DM)<D-;/*;50&@B:R('U1X(AQ=RO_?67N\FD,WJ=?3K.:Y1_
M::L!I^V[F\^3_'/HY)^GD]=-0LYPO"P)\?LC6V&')VX[$W(Z'&="?,_V]I&E
M)3+/[_D*ZTX\9Q]6EK!=S\_DGHQR([O=]EA]]D]';B/7J<"S(M>41B1%G\@M
MNN01.+5)#3(3/PB=AIAJ4!P"I DQEJ&&^+3&K!'@$WVWO@C(WXV(]ZMOFCU7
MH5A)VH3X$$8:XIQSYG/1;/L'I4;1]E6\W*.76!4!EQC?-*HU+,76>)7 \:V<
M/!T3$LV4"P9!AI<D)A*I.7Y-2!/^*Z7:_IS30/"4+R3Z2I&/:;,CIW0FS>@S
M&L%&KQMUAVC2/'K^!?F<-0H<D1L= F<;LT8AA&F[\!ZO)(Z:K<(1*T(^8ADV
M&G*U%H&V<:F$8%H2QM%X3M*T$?Q9K#63/F#([,V1=<[6D0X1DEXW0CYBSHN0
M$;\>ACA*FNVB<5@$_9Y>PTG!Z(++9OVX?H;5,VPLCO='U!=*Y \FIS_I,C0'
MHYI9";V$5FJ?JH<T/J@>,@H%\;D>/N5Z> HWEL:\4*Z">P'_T=HWPJOX@L Y
M?RY]SZ7ON?0]H=*W-R-]9\'3BUO>1FY;Q/NN,=K7-"XH8U=RS<C'5*^3*=@Y
MG\#L_6@^GO'M^MDDA*^:62TC%I!+@;-!)+C\B\KP*L0)Z&1;)0G+5--E-XH2
MGD(;;NE3]4J5U^6ON2BX/%ODZ:^A=#XLS_D\7^>TS0LS0[=R2^JVE+ZU)CA*
M]+',<$X>RPP[9SR2';9WH!TU^_9==N0CI3!3ET.X&D*^ VVZG=PZ.)Z8D;D*
MTU*0;\/YZ<5X&N(YV02Y?9A7;>?8T='[Y\%1L*/O/)8=QXCRHB'NH8:8S\-#
MAWE[7YAGE<90-!1M;*PD+$:W8+C7\2P4X&1@+: '@Z]1 O)256 Q6\8#*Y"B
M?$R,1>APYY=<7^/1DN/;IF6U;J\I=QEM(E(YPFF8$V>KRMYEL<%5'<]56_*P
MOFH]M!5.S_Y9K<B?#!%.%@L22&.4%Z9*HO,94[[G*TG$53B_13.V$I<8O./F
MQW%.4[@2=K8/ C*YNSFI>F4Q9Z;RWRT,"2Q;B%D2XDU=[=7GFYRN>B)V^I=W
MP6#R_7#)1P_E.^=?]%U#KG[VW>/Z;I,[2$R<><41 71% B.5' 86%S+D4.Z2
MD 83 <V4R43P H)DIAR F/H+O?(,N2D5SJT^.7]%+(.&3E[2)1(4BK ,!2$7
M<N/O[Y-J=XS7^BR!;814,F35%\I#B<$],W)#V%0E\Z[:)@N%V^)4S;L:OB9@
M2\-Z;ITM)__;7M0]M!<]1O.CF> >LX=SFWJXPD6L_UC6'ODRWSEPVSK> U[F
M$RQ#I'[!?8J*@!&K8KZZKT_Y)9P[M'OQ@2";_-;;I/;=X Q\U*M:I60K$3]+
M!WP?D@9CC%OT-%^/%&*MIK&MQMHQ#'F 6/,,H68XWX=%FAHSU8NL.8T*;T'5
M0.4_V]0-:/8--!R1!5XQF;8VH^1."CS<_N\-L,+$CN'MB[\!4$L#!!0    (
M *LX9%JG;?]W@P0  ,T1   8    >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL
MC9AO<^(V$,:_BL;M=-J9)/Z'$TB!&4*2:WK)'0VT-]-.7PA;@.9DRY5D(-^^
M*YO8]&K6O $;K,<_:5?/KCW<2?55;Q@S9)^*3(^<C3'YK>OJ>,-2JJ]DSC+X
M9R552@V<JK6K<\5H4@Y*A1MXWK6;4IXYXV'YVTR-A[(P@F=LIH@NTI2JMSLF
MY&[D^,[[#Z]\O3'V!W<\S.F:S9GY/9\I.'-KE82G+--<9D2QU<B9^+=WP;4=
M4%[Q!V<[?71,[%264GZU)T_)R/$L$1,L-E:"PM>639D05@DX_CF(.O4][<#C
MXW?UQW+R,)DEU6PJQ1>>F,W(Z3LD82M:"/,J=[^PPX0BJQ=+H<M/LJNN[7D.
MB0MM9'H8# 0ISZIONC\LQ/& \,2 X# @*+FK&Y64]]30\5#)'5'V:E"S!^54
MR]$ QS,;E;E1\"^'<69\+^,"%MD0FB7D(3/<O)&GK(HVK-K0-7 3>ZD;'P3O
M*L'@A. +55?$ZUV0P NB_PYW@:T&#&K H-0+3^A-Y98I\M=DJ8V"$/[=1E0I
M]-H5;%[?ZIS&;.1 XFJFMLP9__"=?^W]C/"%-5^(J8_G+"Z47;6'?;RAV9J1
M3S1E;92XSJ?)_'[R&P+4JX%ZJ- $PIF4(7T4=-T&@H]?4:$9PA'5'!&J<TBF
M*9 H*B"I$K8G']E;&Q&NY'F>'X4]/PP1K.L:ZQH5JQ-^\9:WA@D?WK_\B$#<
MU! WYT',F.+2;KR$P/9MY<&5RNU6[K>N#=>OV?KGQ.V5K;G=<@!Y*J%QG2D5
M,7]A"8_I!40_OD+8!C7;X!PV4),JEZJT*#(WL')D*@M(-,@WF;3"XL+W#PB=
M[S5FZIW#]\@%V$"1+IEJ-5!<!++],AQ$81]#.O)W_QRD!=V3IP12CJ\@(.6Z
M(8"X9"^Z#'PH^S<#C+ Q>!_UYW?"29* .^N+]P/R#->1SUEK-#LD(R^"1*#:
MD#M9"+:E*B%SZ$DV&'#C^#YNU2CP8B=;@3NJ2,$AAT/O!@-L*H"/6_BW@%-[
M)A59R%U[1<?EGBGY50I!,;:F*OAGE86:K=J] #=3<LNSN#W<N.9T@J$UE<''
MO?U;M)G4!BK7GSP_Z2H=BH/ "]&0-@7#QWV^#.$$^N[3*+C C_VH_Q.&TM0'
M'S?V9QG#JLPV,D--#A<91,%E%'D>1M14!1]W[R_0@!F6P=*D:9$=_$VW4N%"
M7;U/T%2" #?QN10\YH9G:_("":XX%:V=*Z[2R=.4@0#W[)EBY?(PV&%5^P-=
M(C36GU>K]OAUZ'62'?7WN%?_C^Q)ZP+(.@%QV4[ QNZ#,SM\/UB2!3>B=?MU
MB-@9EKV*C+]>D.^]*]O47I"<*K*EHF DA[GJ#54H<U,! MRR%XHF-O?F;^E2
MMF<>+C"=/$\QDL;O@[/\_B%E:FV)/H""V=B(YS1K?1CH$#2J0->HL?O@++M_
MV!-8K4SSLBFJ&O)6+%SM9+ZY1P_G]D4'=.RP$)H(M@(A[^H&IJNJ=P?5B9%Y
M^;R^E :>_LO##:.P%^P%\/]*2O-^8E\!U&]PQO\"4$L#!!0    ( *LX9%J?
MH!OPL0(  .(,   -    >&PO<W1Y;&5S+GAM;-U7;6O;,!#^*T(_8&YB:N*1
M&+9 8;"-0O-A7Y58=@1Z\62Y<_KKI[-L)VEU9=V'L<VAR=T]NKM'=R>9KEMW
MDOSAR+DCO9*ZW="C<\W[)&D/1ZY8^\XT7'ND,E8QYU5;)VUC.2M;<%(R6=[<
M9(EB0M-BK3MUIUQ+#J;3;D-O:%*L*Z//EI0&@U_*%">/3&[HEDFQMV)8RY20
MIV!>@N%@I+'$>2I\0Q=@:9\"O @:L!SC**&-!6,2,H3O_;C\&3!IK5>%E#/!
M)0V&8MTPY[C5=UX9%@_&%Q 9Y=VI\0QKRTZ+Y2T].PP_/LG>V)+;.<V"3J9B
M+7D%=*RHC_#K3), Z)Q17B@%JXUF X?)8Q1\V .7\@%:^*VZBMU7)/3B4PEM
M(+#52?2$1C&$"0K$OXP68E^$O?VML*01C\9][/QN]*!_[XSC]Y97HA_TOIKS
M8]$7>'36-/+T08I:*Q[V_LL)BS6;_,C16/'DL\&D'+R!6TH>N77B<&GY85FS
MX[V;IJFO<,[+?Y#SGZUSS36W3%Z2]J/_-U?Y+8R3\?1<'-&K SI;"5R$&_H5
M[E=YYD#VG9!.Z%$[BK+D^L4Y]>$=V_L+_"J^7U_RBG72[69P0\_R%UZ*3N7S
MJGNHR[CJ+'^&^VB1S;>PSR5TR7M>;D?5UOM!)%[P6<<'')XC=\,31S"?@,41
MP+ \& /,)WAA>?ZG_:S0_00,X[:*(BO49X7Z!*\8LAT^6)ZX3^Z?^$[S/$VS
M#*OH=AMEL,7JEF7P%X^&<0,/+ ]D>ENM\6[C$_+Z'& ]?6U"L)WBDXCM%*\U
M(/&Z@4>>Q[N-Y0$/K O8[$#^>!Z8J;A/FD)7,6[8"<:1/,<0F,7XC&894IT,
M/O'^8*<D3?,\C@ 69Y"F& *G$4<P!L !0])T> \^>Q\ETWLJ.?]74_P$4$L#
M!!0    ( *LX9%J7BKL<P    !,"   +    7W)E;',O+G)E;'.=DKENPS ,
M0'_%T)XP!] AB#-E\18$^0%6H@_8$@6*19V_K]JE<9 +&7D]/!+<'FE [3BD
MMHNI&/T04FE:U;@!2+8ECVG.D4*NU"P>-8?20$3;8T.P6BP^0"X99K>]9!:G
M<Z17B%S7G:4]VR]/06^ KSI,<4)I2$LS#O#-TG\R]_,,-47E2B.56QIXT^7^
M=N!)T:$B6!::1<G3HAVE?QW']I#3Z:]C(K1Z6^CY<6A4"H[<8R6,<6*T_C6"
MR0_L?@!02P,$%     @ JSAD6APX9>H_ 0  / (   \   !X;"]W;W)K8F]O
M:RYX;6R-4<MNPD ,_)75?D 34(M41+B4/I"J%I6*^Y)UB,4^(J\#+5]?)U%4
MI%YZ\GILC6=F%^=(QWV,1_7E74B%KIF;>9:EL@9OTDUL(,BDBN0-2TN'+#4$
MQJ8:@+W+IGD^R[S!H)>+D6M#V743&4K&& 3L@!W".?W.NU:=,.$>'?)WH?NW
M ZT\!O1X 5OH7*M4Q_-+)+S$P,9M2XK.%7HR#'9 C.4?>-N)_#3[U"-L]A]&
MA!1ZE@MAA92XW^CYC6@\@2P/7<OQ"1T#K0S#,\6VP7#H:,1%=F6CSV&L0XAS
M^D^,L:JPA%4L6P^!AQP)7"<PI!J;I%4P'@H]KB@3K'H,+"&I=1BH9+=S*J?7
M=G#-(O<J0YJC#&AM!^&C6@L5!K!O<B )+LF5&U)=Z7FFMW>3>TFH=>Y!L/?P
M&HT=S8\?M_P!4$L#!!0    ( *LX9%HD'INBK0   /@!   :    >&PO7W)E
M;',O=V]R:V)O;VLN>&UL+G)E;'.UD3T.@S ,A:\2Y0 U4*E#!4Q=6"LN$ 7S
M(Q(2Q:X*MR^% 9 Z=&&RGBU_[\E.GV@4=VZ@MO,D1FL&RF3+[.\ I%NTBB[.
MXS!/:A>LXEF&!KS2O6H0DBBZ0=@S9)[NF:*<//Y#='7=:7PX_;(X\ \PO%WH
MJ45D*4H5&N1,PFBV-L%2XLM,EJ*H,AF**I9P6B#BR2!M:59]L$].M.=Y%S?W
M1:[-XPFNWPQP>'3^ 5!+ P04    " "K.&1:99!YDAD!  #/ P  $P   %M#
M;VYT96YT7U1Y<&5S72YX;6RMDTU.PS 0A:\295LE+BQ8H*8;8 M=< %C3QJK
M_I-G6M+;,T[:2J 2%85-K'C>O,^>EZS>CQ&PZ)WUV)0=47P4 E4'3F(=(GBN
MM"$Y2?R:MB)*M9-;$/?+Y8-0P1-XJBA[E.O5,[1R;ZEXZ7D;3?!-F<!B63R-
MPLQJ2AFC-4H2U\7!ZQ^4ZD2HN7/08&<B+EA0BJN$7/D=<.I[.T!*1D.QD8E>
MI6.5Z*U .EK >MKBRAE#VQH%.JB]XY8:8P*IL0,@9^O1=#%-)IXPC,^[V?S!
M9@K(RDT*$3FQ!'_'G2/)W55D(TADIJ]X(;+U[/M!3EN#OI'-X_T,:3?D@6)8
MYL_X>\87_QO.\1'"[K\_L;S63AI_YHOA/UY_ 5!+ 0(4 Q0    ( *LX9%H'
M04UB@0   +$    0              "  0    !D;V-0<F]P<R]A<' N>&UL
M4$L! A0#%     @ JSAD6AC"?+GN    *P(  !$              ( !KP
M &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @ JSAD6IE<G",0!@  G"<
M !,              ( !S $  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4
M    " "K.&1:IVW_=X,$  #-$0  &               @($-"   >&PO=V]R
M:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @ JSAD6I^@&_"Q @  X@P
M  T              ( !Q@P  'AL+W-T>6QE<RYX;6Q02P$"% ,4    " "K
M.&1:EXJ[',     3 @  "P              @ &B#P  7W)E;',O+G)E;'-0
M2P$"% ,4    " "K.&1:'#AEZC\!   \ @  #P              @ &+$
M>&PO=V]R:V)O;VLN>&UL4$L! A0#%     @ JSAD6B0>FZ*M    ^ $  !H
M             ( !]Q$  'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QS4$L!
M A0#%     @ JSAD6F60>9(9 0  SP,  !,              ( !W!(  %M#
G;VYT96YT7U1Y<&5S72YX;6Q02P4&      D "0 ^ @  )A0

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>24</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d824505d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imetrix.edgar-online.com//20250304/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>calc-20250304.xsd</File>
    <File>calc-20250304_lab.xml</File>
    <File>calc-20250304_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" original="d824505d8k.htm">d824505d8k.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="24">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "d824505d8k.htm": {
   "nsprefix": "calc",
   "nsuri": "http://imetrix.edgar-online.com/20250304",
   "dts": {
    "schema": {
     "local": [
      "calc-20250304.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/naics/2024/naics-2024.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "calc-20250304_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "calc-20250304_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "d824505d8k.htm"
     ]
    }
   },
   "keyStandard": 24,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 3,
    "http://xbrl.sec.gov/dei/2024": 3
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 25,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2024": 24
   },
   "report": {
    "R1": {
     "role": "http://imetrix.edgar-online.com//20250304/taxonomy/role/DocumentDocumentAndEntityInformation",
     "longName": "100000 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "duration_2025-03-04_to_2025-03-04",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d824505d8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "duration_2025-03-04_to_2025-03-04",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d824505d8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://imetrix.edgar-online.com//20250304/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://imetrix.edgar-online.com//20250304/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "terseLabel": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://imetrix.edgar-online.com//20250304/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://imetrix.edgar-online.com//20250304/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "terseLabel": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://imetrix.edgar-online.com//20250304/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://imetrix.edgar-online.com//20250304/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "terseLabel": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://imetrix.edgar-online.com//20250304/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://imetrix.edgar-online.com//20250304/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://imetrix.edgar-online.com//20250304/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://imetrix.edgar-online.com//20250304/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://imetrix.edgar-online.com//20250304/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://imetrix.edgar-online.com//20250304/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Ex Transition Period",
        "terseLabel": "Entity Ex Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://imetrix.edgar-online.com//20250304/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "terseLabel": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://imetrix.edgar-online.com//20250304/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation State Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://imetrix.edgar-online.com//20250304/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://imetrix.edgar-online.com//20250304/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://imetrix.edgar-online.com//20250304/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://imetrix.edgar-online.com//20250304/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://imetrix.edgar-online.com//20250304/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://imetrix.edgar-online.com//20250304/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security 12b Title",
        "terseLabel": "Security 12b Title",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://imetrix.edgar-online.com//20250304/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://imetrix.edgar-online.com//20250304/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://imetrix.edgar-online.com//20250304/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://imetrix.edgar-online.com//20250304/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "terseLabel": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0001193125-25-044830-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-25-044830-xbrl.zip
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M,GL8U]YVA>O&F:W/<WO3G_OFJMD[]/,W4$L#!!0    ( *LX9%K[G3$_K 8
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M$W!0KM;8M1A$GJW^_'3.SJ5Q/&4B+<ILN3[;?PEU=N6S^>.6139W3HWMHBK
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MK]VC=[WPKA>VHA?.0N92$H306P8:N1?;N41K>)-BFA-+@@+0)*X,P%A!/D(
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MZ;,PA=-_@O19IV8T@S\&] =A:GD.]A>%:+.Q"J/;_]<8W3<1$#&@N<LV=O8
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M'QX>%H,ZJ;F^DMJ\5+2&G _00^U2J3M"Q@U8BFF<U?^#7GA[F([U(BHXGF+
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M,S T+GAS9%!+ 0(4 Q0    ( *LX9%K[G3$_K 8  *-)   5
M  "  6\#  !C86QC+3(P,C4P,S T7VQA8BYX;6Q02P$"% ,4    " "K.&1:
M==S>.^8$   .+@  %0              @ %."@  8V%L8RTR,#(U,#,P-%]P
M<F4N>&UL4$L! A0#%     @ JSAD6O:]1WY9&   O8H   X
M ( !9P\  &0X,C0U,#5D.&LN:'1M4$L! A0#%     @ JSAD6E][]ANA$
MP4$  !$              ( !["<  &0X,C0U,#5D97@Y.3$N:'1M4$L%!@
0   %  4 0 $  +PX      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>d824505d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="calc-20250304.xsd" xlink:type="simple"/>
    <context id="duration_2025-03-04_to_2025-03-04">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
        </entity>
        <period>
            <startDate>2025-03-04</startDate>
            <endDate>2025-03-04</endDate>
        </period>
    </context>
    <dei:SecurityExchangeName
      contextRef="duration_2025-03-04_to_2025-03-04"
      id="Hidden_dei_SecurityExchangeName">NASDAQ</dei:SecurityExchangeName>
    <dei:AmendmentFlag contextRef="duration_2025-03-04_to_2025-03-04" id="ixv-323">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="duration_2025-03-04_to_2025-03-04"
      id="Hidden_dei_EntityCentralIndexKey">0001534133</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="duration_2025-03-04_to_2025-03-04" id="ixv-334">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2025-03-04_to_2025-03-04" id="ixv-335">2025-03-04</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="duration_2025-03-04_to_2025-03-04" id="ixv-336">CalciMedica, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2025-03-04_to_2025-03-04" id="ixv-337">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2025-03-04_to_2025-03-04" id="ixv-338">001-39538</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="duration_2025-03-04_to_2025-03-04" id="ixv-339">45-2120079</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2025-03-04_to_2025-03-04" id="ixv-340">505 Coast Boulevard South</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="duration_2025-03-04_to_2025-03-04" id="ixv-341">Suite 307</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="duration_2025-03-04_to_2025-03-04" id="ixv-342">La Jolla</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="duration_2025-03-04_to_2025-03-04" id="ixv-343">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="duration_2025-03-04_to_2025-03-04" id="ixv-344">92037</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="duration_2025-03-04_to_2025-03-04" id="ixv-345">(858)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2025-03-04_to_2025-03-04" id="ixv-346">952-5500</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2025-03-04_to_2025-03-04" id="ixv-347">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2025-03-04_to_2025-03-04" id="ixv-348">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2025-03-04_to_2025-03-04" id="ixv-349">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2025-03-04_to_2025-03-04" id="ixv-350">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="duration_2025-03-04_to_2025-03-04" id="ixv-351">Common Stock, $0.0001, par value per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2025-03-04_to_2025-03-04" id="ixv-352">CALC</dei:TradingSymbol>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2025-03-04_to_2025-03-04" id="ixv-353">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="duration_2025-03-04_to_2025-03-04" id="ixv-354">false</dei:EntityExTransitionPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
